This September, the National Cancer Institute Small Business Innovation Research Development Center (NCI SBIR) is showcasing its MedTech portfolio virtually for the first time and you are cordially invited to attend to learn more about and meet with our innovative portfolio companies.
If you are a MedTech investor or strategic partner interested in learning more about the top NCI SBIR-funded MedTech companies for potential investments and partnerships, join us September 9-10 for this virtual showcase that will include:
The event platform will open around one month ahead of time so attendees and showcase companies can begin browsing profiles, networking, and requesting partnering meetings that will take place during the event.
When your registration request is approved, you will receive an email from the event system asking you to log in and fill out your profile. Registration is complimentary.
The event will showcase 20-30 of the top MedTech startups that were not only selected by peer review for NCI funding, but were additionally selected for this event by a panel of more than 70 investors and partners based on the technology's level of innovation and the company's readiness to pitch, establish partnerships, and raise funding.
TIME |
SESSION |
|
All Day |
Partnering Meetings |
|
12:00 p.m. - 12:45 p.m. |
Keynote Address: Ned Sharpless, Director of the National Cancer Institute Please click the link below to join the webinar:
Passcode: 455434
|
|
12:45 p.m. - 1:15 p.m. |
Overview of the Showcase and NCI SBIR/STTR Programs Please click the link below to join the webinar:
Passcode: 455434
|
TIME |
SESSION |
|
All Day |
Partnering Meetings |
|
3:30 p.m. - 4:45 p.m. |
MedTech Investment Panel
Please click the link below to join the webinar:
Passcode: 978657
|
|
4:45 p.m. - 5:00 p.m. |
Closing Remarks |
NCI SBIR is NCI's engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. NCI SBIR is one of the largest sources of early stage funding for life sciences companies operating in the cancer space. At any given time, our portfolio consists of more than 200 companies developing diagnostics, medical devices, research tools, and health IT tools among a total portfolio of more than 400 companies.
Learn more: https://sbir.cancer.gov/
If you have any questions or have trouble requesting to register, please email Brittany Connors at brittany.connors@nih.gov.